Donors Delivering for SRHR is an annual publication analysing and ranking the latest data available to track the disbursements of members of the Organisation for Economic Co-operation and Development (OECD)’s Development Assistance Committee (DAC) to SRHR, reproductive, maternal, newborn and child health (RMNCH), and family planning (FP), as part of their Official Development Aid (ODA).
2022 REPORT KEY FINDINGS
In 2020, after a drop in disbursements in 2019, donors’ SRHR funding was back to the level of 2018. This is mainly due to several large donors increasing the total amount of their SRHR disbursements, including the US, Canada, Germany, Japan, and the EU Institutions.
Disappointingly, the latest data confirms a trend from previous years of large donors failing to prioritise SRHR funding in their ODA. This means that many countries who contribute the highest amount of SRHR funding in real terms only allocate a comparatively small percentage of their ODA to supporting SRHR. Accordingly, donors such as Germany, the EU Institutions, or France, who are some of the leading donors in ‘real terms’, lag behind smaller donors such as Iceland and the Netherlands when it comes to prioritising SRHR in their ODA budgets.
While jointly the largest ODA donors (accounting for more than 50% of all ODA), the EU Institutions and EU Member States taken together account for only 25.12% of all donors’ SRHR disbursements in 2020.
FOLLOW US ON TWITTER
Innovative funding solutions are needed to better address #NTD priorities. On ...the markets where fit-for-purpose #diagnostics & treatments are available, pooled procurement can lower product & distribution costs.
Our VP, External Affairs, @WilloBrock:
https://www.devex.com/news/opinion-the-business-case-for-investing-in-neglected-tropical-diseases-105145
📢We are live
The Global Health EDCTP3 Twitter is up and running!
Follow us... & stay updated on our work to combat #infectiousdiseases 🥼
What will it take to #EndTB? New and improved tools including shorter, ...simplified treatment regimens, improved treatments for drug-resistant strains, new #vaccines, and improved #diagnostics. 💉💊🔬Learn more in our R&D for #TB fact sheet. #WorldTBDay
#TB is the leading cause of death among women of reproductive age. Women who ...are pregnant or living with #HIV are at an even greater risk. Investing in women's health, including R&I for urgently needed new tools is crucial to ending the TB epidemic.
#YesWeCanEndTB
Stigma and isolation not only harm those with TB, but also contribute to the ...spread of the disease. This #WorldTBDay let's break down the barriers that prevent people from seeking treatment and work towards a TB-free future. #YesWeCanEndTB